Curigliano G - Search Results

1

Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies.

Antonarelli G, Giugliano F, Corti C, Repetto M, Tarantino P, Curigliano G. Antonarelli G, et al. Among authors: curigliano g. Pharmaceuticals (Basel). 2021 Aug 31;14(9):884. doi: 10.3390/ph14090884. Pharmaceuticals (Basel). 2021. PMID: 34577584 Free PMC article. Review.

2

Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.

Morganti S, Tarantino P, Ferraro E, D'Amico P, Viale G, Trapani D, Duso BA, Curigliano G. Morganti S, et al. Among authors: curigliano g. Crit Rev Oncol Hematol. 2019 Jan;133:171-182. doi: 10.1016/j.critrevonc.2018.11.008. Epub 2018 Nov 26. Crit Rev Oncol Hematol. 2019. PMID: 30661654 Review.

3

Defining the immunogram of breast cancer: a focus on clinical trials.

Tarantino P, Curigliano G. Tarantino P, et al. Among authors: curigliano g. Expert Opin Biol Ther. 2019 May;19(5):383-385. doi: 10.1080/14712598.2019.1598372. Epub 2019 Apr 1. Expert Opin Biol Ther. 2019. PMID: 30892954 Free article.

4

Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.

Morganti S, Tarantino P, Ferraro E, D'Amico P, Duso BA, Curigliano G. Morganti S, et al. Among authors: curigliano g. Adv Exp Med Biol. 2019;1168:9-30. doi: 10.1007/978-3-030-24100-1_2. Adv Exp Med Biol. 2019. PMID: 31713162 Review.

5

Biologic therapy for advanced breast cancer: recent advances and future directions.

Tarantino P, Morganti S, Curigliano G. Tarantino P, et al. Among authors: curigliano g. Expert Opin Biol Ther. 2020 Sep;20(9):1009-1024. doi: 10.1080/14712598.2020.1752176. Epub 2020 Apr 21. Expert Opin Biol Ther. 2020. PMID: 32255704 Free article. Review.

6

Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic.

Tarantino P, Trapani D, Curigliano G. Tarantino P, et al. Among authors: curigliano g. Eur J Cancer. 2020 Jun;132:8-10. doi: 10.1016/j.ejca.2020.03.023. Epub 2020 Apr 6. Eur J Cancer. 2020. PMID: 32305011 Free PMC article. No abstract available.

7

HER2-Low Breast Cancer: Pathological and Clinical Landscape.

Tarantino P, Hamilton E, Tolaney SM, Cortes J, Morganti S, Ferraro E, Marra A, Viale G, Trapani D, Cardoso F, Penault-Llorca F, Viale G, Andrè F, Curigliano G. Tarantino P, et al. Among authors: curigliano g. J Clin Oncol. 2020 Jun 10;38(17):1951-1962. doi: 10.1200/JCO.19.02488. Epub 2020 Apr 24. J Clin Oncol. 2020. PMID: 32330069 Review. No abstract available.

8

Atezolizumab and Bevacizumab in Hepatocellular Carcinoma.

Tarantino P, Curigliano G. Tarantino P, et al. Among authors: curigliano g. N Engl J Med. 2020 Aug 13;383(7):694-695. doi: 10.1056/NEJMc2021840. N Engl J Med. 2020. PMID: 32786200 No abstract available.

9

Adjuvant treatment of early male breast cancer.

Corti C, Crimini E, Criscitiello C, Trapani D, Curigliano G. Corti C, et al. Among authors: curigliano g. Curr Opin Oncol. 2020 Nov;32(6):594-602. doi: 10.1097/CCO.0000000000000678. Curr Opin Oncol. 2020. PMID: 32852309 Review.

10

Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents.

Tarantino P, Marra A, Gandini S, Minotti M, Pricolo P, Signorelli G, Criscitiello C, Locatelli M, Belli C, Bellomi M, Curigliano G. Tarantino P, et al. Among authors: curigliano g. Eur J Cancer. 2020 Nov;139:92-98. doi: 10.1016/j.ejca.2020.08.026. Epub 2020 Sep 24. Eur J Cancer. 2020. PMID: 32979647 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

757 results

Search Page